Recon: FDA panel recommends withdrawing Makena; Merck affiliate under investigation in France over reformulation of thyroid drug

ReconReconBiologicsBiotechnologyDiagnosticsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy